Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published August 17, 2023 | Supplemental Material
Journal Article Open

Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharide libraries for decoding glycosaminoglycan–protein interactions

Abstract

Glycosaminoglycans (GAGs) are abundant, ubiquitous carbohydrates in biology, yet their structural complexity has limited an understanding of their biological roles and structure–function relationships. Synthetic access to large collections of well defined, structurally diverse GAG oligosaccharides would provide critical insights into this important class of biomolecules and represent a major advance in glycoscience. Here we report a new platform for synthesizing large heparan sulfate (HS) oligosaccharide libraries displaying comprehensive arrays of sulfation patterns. Library synthesis is made possible by improving the overall synthetic efficiency through universal building blocks derived from natural heparin and a traceless fluorous tagging method for rapid purification with minimal manual manipulation. Using this approach, we generated a complete library of 64 HS oligosaccharides displaying all possible 2-O-, 6-O- and N-sulfation sequences in the tetrasaccharide GlcN–IdoA–GlcN–IdoA. These diverse structures provide an unprecedented view into the sulfation code of GAGs and identify sequences for modulating the activities of important growth factors and chemokines.

Additional Information

© The Author(s), under exclusive licence to Springer Nature Limited 2023. Financial support was provided by the National Institutes of Health (NIH U01 GM116262 to L.C.H.-W. and X.H., R44 GM134738 to V. Pagadala, L.C.H.-W. and X.H., U01 GM116248 to N.L.B.P., and T32 GM109825 and T32 GM131994 to M.K.K.) and the National Science Foundation (DGE-1745301 to A.W.S.). We thank M. Shahgholi in the CCE Division Mass Spectrometry Facility and D. Vander Velde in the CCE Division NMR Facility at Caltech for technical support. Data availability: All data associated with this report are contained within the manuscript or the Supplementary Information. Source data are provided with this Paper. Code availability: All code associated with this report is publicly available at https://doi.org/10.5281/zenodo.7787616. Contributions: L.W., A.W.S., B.-S.H., N.P., X.H., J.L., N.L.B.P. and L.C.H.-W. designed the research. L.W., A.W.S., B.-S.H., M.K.K. and G.S. performed the research. L.W., A.W.S., B.-S.H. and L.C.H.-W. wrote the paper. Competing interests: J.L. is a founder and chief scientific officer of Glycan Therapeutics. G.S. is an employee of Glycan Therapeutics and has stock options from the company. The remaining authors declare no competing interests.

Attached Files

Supplemental Material - 41557_2023_1248_MOESM1_ESM.pdf

Supplemental Material - 41557_2023_1248_MOESM3_ESM.xlsx

Supplemental Material - 41557_2023_1248_MOESM4_ESM.xlsx

Supplemental Material - 41557_2023_1248_MOESM5_ESM.xlsx

Files

41557_2023_1248_MOESM1_ESM.pdf
Files (22.0 MB)
Name Size Download all
md5:4dbf3fbe84070406c296731140ee101a
20.4 kB Download
md5:f34b2d735e1dc63f21a70547c30b80b6
22.0 MB Preview Download
md5:9a934303c2b1c520e8e02a702292ca70
20.5 kB Download
md5:25d6372a78823399e976fd22de2d9f59
21.7 kB Download

Additional details

Created:
August 22, 2023
Modified:
October 23, 2023